Current Signal Transduction Therapy

Editor-in-Chief

Jingxuan Yang
Department of Medicine
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor

The Role of Parthenolide in Intracellular Signalling Processes: Review of Current Knowledge

Volume:3   Issue: 2
Pp: 82-87
Luis Miguel Bedoya, Maria Jose Abad and Paulina Bermejo
DOI: 10.2174/157436208784223134

Intracellular Signaling Triggered by Formyl-Peptide Receptors in Nonphagocytic Cells

Volume:3   Issue: 2
Pp: 88-96
Annalisa Iaccio, Antonella Angiolillo and Rosario Ammendola
DOI: 10.2174/157436208784223152

Novel Therapeutic Targets for the Treatment of Tubulointerstitial Fibrosis

Volume:3   Issue: 2
Pp: 97-111
Jai Prakash, Klaas Poelstra, Harry van Goor, Frits Moolenaar, Dirk K.F. Meijer and Robbert J. Kok
DOI: 10.2174/157436208784223161

Signal Transduction Targets in Prostate Cancer

Volume:3   Issue: 2
Pp: 112-128
Hari K. Koul and Lakshmipathi Khandrika
DOI: 10.2174/157436208784223143

Pathogen-Related Signal Transduction Pathways of Dendritic Cells: Perspectives for Cancer Immunotherapy

Volume:3   Issue: 2
Pp: 133-137
Tomonori Kato, Yasuji Ueda, Hiroaki Kinoh, Kaori Tsukada, Tomohiko Ichikawa and Yoshikazu Yonemitsu
DOI: 10.2174/157436208784223116

Regulation of the PI3K-Akt Network: Current Status and a Promise for the Treatment of Human Diseases

Volume:3   Issue: 2
Pp: 138-151
Masayuki Noguchi, Toshiyuki Obata and Futoshi Suizu
DOI: 10.2174/157436208784223189